Does interferon beta help in secondary progressive MS?

被引：12

作者：

Cohen, JA ^{[1
]}

Antel, JP ^{[1
]}

机构：

[1] Montreal Neurol Hosp, Montreal, PQ, Canada

来源：

NEUROLOGY | 2004年 / 63卷 / 10期

关键词：

D O I：

10.1212/01.WNL.0000147171.32178.48

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1768 / 1769

页数：2

共 16 条

[1] Benefit of interferon β-1a on MSFC progression in secondary progressive MS
Cohen, JA
Cutter, GR
Fischer, JS
Goodman, AD
Heidenreich, FR
Kooijmans, MF
Sandrock, AW
Rudick, RA
Simon, JH
Simonian, NA
Tsao, EC
Whitaker, JN
[J]. NEUROLOGY, 2002, 59 (05) : 679 - 687
[2] Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO
[3] 2-#
[4] Rate of pregnancy-related relapse in multiple sclerosis
Confavreux, C
Hutchinson, M
Hours, MM
Cortinovis-Tourniaire, P
Moreau, T
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (05) : 285 - 291
[5] Whole brain volume changes in patients with progressive MS treated with cladribine
Filippi, M
Rovaris, M
Iannucci, G
Mennea, S
Sormani, MP
Comi, G
[J]. NEUROLOGY, 2000, 55 (11) : 1714 - 1718
[6] Eight-year follow-up study of brain atrophy in patients with MS
Fisher, E
Rudick, RA
Simon, JH
Cutter, G
Baier, M
Lee, JC
Miller, D
Weinstock-Guttman, B
Mass, MK
Dougherty, DS
Simonian, NA
[J]. NEUROLOGY, 2002, 59 (09) : 1412 - 1420
[7] Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis
Kappos, L
Polman, C
Pozzilli, C
Thompson, A
Dahlke, F
Knight, R
Hern, J
Coleman, R
Gerrie, L
Cooper, G
Moore, J
Boringa, J
van Oosten, B
Ronner, H
Schrijver, H
Truyen, L
Montalbán, J
Río, J
Tintoré, M
Jacas, C
Marzo, E
Lechner-Scott, J
Huber, S
Lienert, C
Brunnschweiler, H
Hawkins, S
Droogan, A
McDonnell, G
Duddy, M
McKinstry, S
Altenkirch, H
Baum, K
Einhäupl, K
Marx, P
Poewe, W
Walter, G
Akman, H
Brockmeier, B
Scherer, P
Zschenderlein, R
Schmierer, K
Gelderblom, H
Hartmann, A
Stapf, C
Lüschow, A
Mackert, B
Schumacher, H
Masuhr, F
Hempel, T
Zimmermann, R
[J]. LANCET, 1998, 352 (9139) : 1491 - 1497
[8] Interferon beta-1b in secondary progressive MS - A combined analysis of the two trials
Kappos, L
Weinshenker, B
Pozzilli, C
Thompson, AJ
Dahlke, F
Beckmann, K
Polman, C
McFarland, H
[J]. NEUROLOGY, 2004, 63 (10) : 1779 - 1787
[9] Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis
Kappos, L
Moeri, D
Radue, EW
Schoetzau, A
Schweikert, K
Barkhof, F
Miller, D
Guttmann, CRG
Weiner, HL
Gasperini, C
Filippi, M
[J]. LANCET, 1999, 353 (9157) : 964 - 969
[10] King J, 2001, NEUROLOGY, V56, P1496

← 1 2 →